Early treatment of T2D targets three different pathways, alone or in combination by: 1) improving insulin sensitivity via either changes in lifestyle or pharmacologic approaches; 2) increasing insulin secretion; and 3) reducing kidney glucose reabsorption (17). Here, INS is linked to type 2 diabetes mellitus.